Acute Lymphoblastic Leukemia: Challenges in MRD Testing
2 意见
• 08/04/23
0
0
嵌入
Mark R. Litzow, MD; Aaron C. Logan, MD, PhD; Bijal D. Shah, MD; and Ryan D. Cassaday, MD, reflect on challenges presented by minimal residual disease testing in acute lymphoblastic leukemia, such as lack of standardization, risk of oversensitivity, and constantly evolving data in this setting.
显示更多
脸书评论
SORT BY-
热门评论
-
最新评论